These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 4717947

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Plasma myocardial depressant activity (shock factor) identified as salt in the cat papillary muscle bioassay system.
    Wangensteen SL, Ramey WG, Ferguson WW, Starling JR.
    J Trauma; 1973 Mar; 13(3):181-94. PubMed ID: 4695067
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Myocardial depressant factor. A peptide: its significance in cardiogenic shock.
    Okuda M, Fukui T.
    Jpn Circ J; 1974 Jun; 38(6):497-508. PubMed ID: 4436943
    [No Abstract] [Full Text] [Related]

  • 7. MDF: its participation in the pathophysiology of shock.
    Okada K, Kosugi I, Tanokura Y, Tajimi K, Ohmura A, Innami H, Tsukamoto T, Inaba T.
    Prog Clin Biol Res; 1983 Jun; 111():125-46. PubMed ID: 6867021
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Further characterization of a myocardial depressant factor present in hemorrhagic shock.
    Brand E, Cowgill R, Lefer AM.
    J Trauma; 1969 Mar; 9(3):216-26. PubMed ID: 5766837
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Myocardial depressant factor in plasma from cats in irreversible post-oligemic shock.
    Brand ED, Lefer AM.
    Proc Soc Exp Biol Med; 1966 May; 122(1):200-3. PubMed ID: 5944874
    [No Abstract] [Full Text] [Related]

  • 16. [Methods of determination, physico-chemical properties and pharmacokinetic signifance of plasma protein binding of drugs].
    Krieglstein J.
    Arzneimittelforschung; 1973 Nov; 23(11):1527-9. PubMed ID: 4801656
    [No Abstract] [Full Text] [Related]

  • 17. Role of a myocardial depressant factor in the pathogenesis of circulatory shock.
    Lefer AM.
    Fed Proc; 1970 Nov; 29(6):1836-47. PubMed ID: 5482718
    [No Abstract] [Full Text] [Related]

  • 18. Evidence for a role of platelet activating factor in hypovolemic shock in the rat.
    Zingarelli B, Squadrito F, Bussolino F, Calapai G, Altavilla D, Ioculano M, Campo GM, Canale P, Caputi AP.
    J Lipid Mediat Cell Signal; 1994 Mar; 9(2):123-34. PubMed ID: 8012759
    [Abstract] [Full Text] [Related]

  • 19. Actions of non-cardiodepressant beta-adrenergic blocking agents in hemorrhagic shock.
    Lefer AM, Lefer DJ, Levin RJ.
    Adv Shock Res; 1980 Mar; 3():167-74. PubMed ID: 6118024
    [Abstract] [Full Text] [Related]

  • 20. Characterization of circulating shock-induced cardiodepressant substances.
    Goldfarb RD, Weber P, Estes JE.
    Fed Proc; 1978 Nov; 37(13):2724-8. PubMed ID: 710593
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.